Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR

[Image: see text] Inhibition of phosphoinositide 3-kinase (PI3K) signaling is an appealing approach to treat brain tumors, especially glioblastoma multiforme (GBM). We previously disclosed our successful approach to prospectively design potent and blood–brain barrier (BBB) penetrating PI3K inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Heffron, Timothy P., Ndubaku, Chudi O., Salphati, Laurent, Alicke, Bruno, Cheong, Jonathan, Drobnick, Joy, Edgar, Kyle, Gould, Stephen E., Lee, Leslie B., Lesnick, John D., Lewis, Cristina, Nonomiya, Jim, Pang, Jodie, Plise, Emile G., Sideris, Steve, Wallin, Jeffrey, Wang, Lan, Zhang, Xiaolin, Olivero, Alan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834666/
https://www.ncbi.nlm.nih.gov/pubmed/27096040
http://dx.doi.org/10.1021/acsmedchemlett.6b00005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834666/
https://www.ncbi.nlm.nih.gov/pubmed/27096040
http://dx.doi.org/10.1021/acsmedchemlett.6b00005

Ejemplares similares